Quidel Corporation (QDEL)

Exchange
NASDAQ
Symbol
QDEL
Sector
Life Sciences
Industry
In Vitro & In Vivo Diagnostic Substances
Description
Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for infectious disease, cardiology, thyroid, general and women's health, eye health, gastrointestinal disease, and toxicology applications globally. The company is headquartered in San Diego, California.
Country
USA

Stock price

At close: November 22, 2024

  • Open
    37.89
  • High
    40.81
  • Low
    37.49
  • Close
    40.14
  • Volume
    4,294,410

Financial ratios

Dec 31, 2023

Activity ratios
Inventory turnover
4.07
Receivables turnover
6.78
Payables turnover
7.98
Working capital turnover
6.29
Days of inventory on hand (DOH)
89.61
Days of sales outstanding (DSO)
53.84
Number of days of payables
45.72
Fixed asset turnover
2.08
Total asset turnover
0.35
 Liquidity ratios
Current ratio
1.57
Quick ratio
0.73
Cash ratio
0.20
Cash conversion cycle
97.73
 Solvency ratios
Debt-to-assets ratio
0.00
Debt-to-capital ratio
0.00
Debt-to-equity ratio
0.00
Financial leverage ratio
1.71
Interest coverage
3.55
 Profitability ratios
Gross profit margin
21.49%
Operating profit margin
4.64%
Pretax margin
-0.97%
Net profit margin
-0.34%
Operating return on assets (Operating ROA)
1.62%
Return on assets (ROA)
-0.12%
Return on total capital
2.78%
Return on equity (ROE)
-0.20%